Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exact Sciences Cor
(NQ:
EXAS
)
52.91
-0.16 (-0.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Cor
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
November 13, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken?
November 06, 2024
The company reported lighter-than-expected third-quarter sales due to issues with physician order rates.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 06, 2024
Via
Benzinga
Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point
November 06, 2024
Exact Sciences Q3 EPS loss of $0.21 fell short of analyst expectations. 2024 revenue guidance lowered amid screening segment hurdles, growth plans set for 2025.
Via
Benzinga
Will EXACT SCIENCES CORP breakout?
October 30, 2024
With a solid technical rating of 8 out of 10, EXACT SCIENCES CORP (NASDAQ:EXAS) is showing strong indications of a possible breakout.
Via
Chartmill
Deep Dive Into Exact Sciences Stock: Analyst Perspectives (7 Ratings)
October 29, 2024
Via
Benzinga
(EXAS) - Analyzing Exact Sciences's Short Interest
October 09, 2024
Via
Benzinga
Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
November 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 06, 2024
Via
Benzinga
Why Tesla Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
November 06, 2024
Via
Benzinga
Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript
November 05, 2024
EXAS earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Analyst Ratings For Exact Sciences
October 01, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Exact Sciences
September 12, 2024
Via
Benzinga
Exact Sciences Stock Plummets After Worse-Than-Expected Q3 Results, FY24 Guidance Below Estimates
November 05, 2024
Exact Sciences shares are dropping after the company reported its third-quarter results after Tuesday's closing bell. Here's a look at the details.
Via
Benzinga
Exact Sciences Announces Third-Quarter 2024 Results
November 05, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences to Participate in November Investor Conference
November 01, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement
October 27, 2024
From
Exact Sciences Corp.
Via
Business Wire
Can This Beaten-Down Cathie Wood Stock Bounce Back?
October 17, 2024
An updated version of Exact Sciences' key product just got regulatory approval. That could help the healthcare stock stage a comeback.
Via
The Motley Fool
Exact Sciences Schedules Third Quarter 2024 Earnings Call
October 08, 2024
From
Exact Sciences Corp.
Via
Business Wire
FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test
October 04, 2024
Exact Sciences' Cologuard Plus test, now FDA-approved, offers a non-invasive screening option for adults 45+ at average risk for colorectal cancer. The test outperformed fecal immunochemical tests in...
Via
Benzinga
Exposures
Product Safety
Exact Sciences Stock Rises After FDA Signs Off On New Cologuard
October 04, 2024
The company is soon to launch its next-generation colon cancer screening tool.
Via
Investor's Business Daily
Exposures
Product Safety
FDA Approves Exact Sciences’ Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening
October 04, 2024
From
Exact Sciences Corp.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
September 18, 2024
Via
Benzinga
Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
September 16, 2024
From
Exact Sciences Corp.
Via
Business Wire
Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
September 15, 2024
These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also raised price targets for Applovin and Arm Holdings.
Via
Benzinga
Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday
September 12, 2024
Via
Benzinga
Exact Sciences to Participate in September Investor Conferences
August 28, 2024
From
Exact Sciences Corp.
Via
Business Wire
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
August 23, 2024
Via
AB Newswire
Exposures
COVID-19
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
August 23, 2024
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
Via
News Direct
Exposures
COVID-19
Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study
August 20, 2024
From
Exact Sciences Corp.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.